Group Health Cooperative Center for Health Studies
Time for a new view of late-life dementia
Published in Drug Week, January 1st, 2010
Two new studies published in the December 16, 2009 issue of the Journal of the American Medical Association point to the need for a broader scientific perspective on late-life dementia, according to an editorial in the same issue by Thomas J. Montine, MD, PhD, University of Washington (UW) professor of neuropathology, and Eric B. Larson, MD, MPH, executive director of Group Health Research Institute.
One study, led by Robert C. Green, MD, MPH, of Boston University School of Medicine, shows that the drug tarenflurbil-which aims to suppress the accumulation of amyloid protein (plaque) in brain tissue-did not slow cognitive decline or loss of usual daily activities.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-01-01)
More Articles from Drug Week
- Albert Einstein College of Medicine
Antidepressants may increase risk of stroke and death - American College of Cardiology
New research identifies modifiable risk factors for heart disease - American Physical Therapy Association
Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy - American Psychological Association
New study links DHA type of omega-3 to better nervous-system function - Boston University Medical Center
Researchers find high leptin levels may protect against Alzheimer's disease and dementia - Burness Communications
New research backs FDA ban on flavored cigarettes - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
